The Department of Health – Abu Dhabi is cooperating with Rafid Company, the leading group procurement institution in the country, the global biopharmaceutical company GlaxoSmithKline, and Etihad Cargo, a subsidiary of Etihad Airways, to obtain the first shipment of the drug “sutrovimab”, which is intended to treat infection with the Covid 19 virus. Abu Dhabi is the first city in the world to receive the new treatment.
Sotrofimab is the latest drug in the world to treat certain cases of people infected with the Covid 19 virus, and it contains monoclonal antibodies given intravenously, and it can be used to treat adults and children over 12 years of age who meet certain criteria and are at risk of developing severe symptoms of Covid 19 for them, by According to the protocols developed by the National Scientific Committee.
Studies have shown that the drug prevents the disease from developing to severe cases or death in more than 85% of early treatment cases, and it can treat all mutated forms known to date..
The Ministry of Health and Community Protection has approved the new drug Sotrovimab, from GlaxoSmithKline, after completing the national evaluation procedures, and after it was approved by the US Food and Drug Administration and granted an emergency use license..
The Department of Health Abu Dhabi signed a cooperation agreement with Rafid Company to ensure the early delivery of the drug, starting from June and July 2021, which makes patients in the UAE among the first in the world to receive this new treatment. The National Scientific Committee and the Department of Health – Abu Dhabi have also developed treatment protocols for the drug to be a reference for doctors in identifying dangerous cases and to ensure that patients receive sotrofimab according to the level of risk and eligibility criteria..
The Abu Dhabi-based Rafid Company will facilitate the process of securing, storing and distributing the property through the Rafid Distribution Center, the largest specialized cold storage facility in the region, which is part of the Hope Coalition, and in cooperation with entities working in the fields of healthcare, logistical support and supply chains. . This comes within the framework of strengthening Abu Dhabi’s continuous efforts to support the medical field and life sciences to address the global health crisis, locally, regionally and internationally.
On this achievement, Dr. Jamal Muhammad Al Kaabi, Undersecretary of the Department of Health – Abu Dhabi, said: “Abu Dhabi continues its efforts to maintain its leading position in the world in terms of flexibility and safety in the time of the Covid 19 pandemic, thanks to the continuous support and guidance of our wise leadership.”
He added: “We are continuing our daily preventive efforts to research, evaluate, identify sources and areas of local and international cooperation, to obtain the best medical solutions for the community children in Abu Dhabi, the UAE and abroad. The new drug is one of the most prominent advanced achievements in the pharmaceutical industry, and it constitutes an effective tool to limit the spread of the emerging corona virus. We look forward to implementing the eligibility criteria for the emergency use of sotrofimab, which reflects Abu Dhabi’s commitment to leading comprehensive efforts to address the Covid 19 virus, prevent its spread, treat and care for those infected with it.”
For his part, Rashid Saif Al Qubaisi, CEO of Rafid, said: “Sotrofimab is a major advance in efforts to tackle the Covid-19 virus. Thanks to the close cooperation with the Department of Health – Abu Dhabi and GlaxoSmithKline, we were able to ensure the supply chain of the drug, in order to ensure Distribute it throughout the country in an effective and timely manner. The Rafid Distribution Center continues to implement its goals of improving the services provided to the residents of the Emirates and transferring Abu Dhabi’s experience in addressing the disease to a larger scale around the world.”
In conjunction with the Department of Health – Abu Dhabi finalizing a comprehensive framework clarifying the criteria for obtaining sutrofimab treatment, Etihad Cargo, the cargo and logistics arm of the Etihad Aviation Group and the Hope Coalition, worked to transfer the first batch of treatment to the UAE through the Pharma Life service. Accredited by the IATA Center of Excellence for Independent Auditors.
In this regard, Tony Douglas, CEO of Etihad Aviation Group, said: “This achievement will contribute to strengthening Abu Dhabi’s leading position in its response to the Covid-19 pandemic, and confirms the great joint capabilities possessed by the institutions cooperating to achieve this achievement. As the national carrier of the United Arab Emirates, the Federation plays a vital role in facilitating the movement of vaccines and medical supplies to and from the Emirates through its specialized services in transporting pharmaceutical products.”
GlaxoSmithKline submitted an emergency use authorization request to the US Food and Drug Administration, after a positive scientific opinion was issued by the Committee for Medicinal Products for Human Use of the European Medicines Agency, and the UAE obtained approval from both sides, which is an important step for the use of the drug in Europe. To treat COVID-19 patients in the early stages.
“We have been working closely with the Department of Health – Abu Dhabi and Rafid since the initial clinical trial results of sotrofimab were available in order to expedite its delivery to patients,” said Jezem Akalin, vice president and general manager of GlaxoSmithKline.
Follow UAE news from Al Bayan via Google News